We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
AUM
$1.04B
AUM Growth
+$175M
Cap. Flow
+$144M
Cap. Flow %
13.94%
Top 10 Hldgs %
70.55%
Holding
33
New
3
Increased
28
Reduced
1
Closed
1

Top Sells

Rank Stock Value
1
NPO icon
Enpro
NPO
+$2.43M
2
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
+$9.46K

Sector Composition

Rank Sector Weight
1 Financials 30.92%
2 Communication Services 19.8%
3 Healthcare 10.04%
4 Consumer Staples 8.21%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALB icon
26
Albemarle
ALB
$13.9B
$4.31M 0.42%
19,306
+157
+0.8% +$32.1K
MO icon
27
Altria Group
MO
$114B
$2.84M 0.27%
62,674
+508
+0.8% +$23K
BNTX icon
28
BioNTech
BNTX
$22.9B
$2.54M 0.24%
23,499
+190
+0.8% +$21.4K
RSKD icon
29
Riskified
RSKD
$694M
$2.49M 0.24%
513,105
+4,124
+0.8% +$20.7K
CTMX icon
30
CytomX Therapeutics
CTMX
$675M
$1.59M 0.15%
925,245
+7,491
+0.8% +$12.4K
DBTX
31
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$596K 0.06%
154,878
-2,577
-2% -$9.46K
NPO icon
32
Enpro
NPO
$6.63B
-23,392
Closed -$2.43M

Similar funds

Bronte Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bronte Capital Management held 33 positions worth $1.04B, up 20% from $862M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bronte Capital Management deployed $144M of net new capital in Q2 2023, opening 3 new positions and adding to 28 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 278,400 shares worth $67.6M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 33% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Decibel Therapeutics, Inc. Common Stock, an estimated $9.46K trimmed.

  • Bronte Capital Management's largest Q2 2023 buy was iShares Russell 2000 ETF: 278,400 shares worth $67.6M.
  • Bronte Capital Management added most to Amazon in Q2 2023, an estimated $19M increase.
  • Bronte Capital Management's biggest Q2 2023 reduction was Decibel Therapeutics, Inc. Common Stock, cutting an estimated $9.46K.
  • Bronte Capital Management fully exited Enpro in Q2 2023, selling an estimated $2.43M.
  • Bronte Capital Management's ten largest holdings make up 71% of its $1.04B portfolio in Q2 2023.
  • Bronte Capital Management opened 3 new positions and closed 1 in Q2 2023.
  • Bronte Capital Management's portfolio value rose 20% quarter-over-quarter to $1.04B.

Based on Bronte Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.